Troubling new details emerge on diabetes ouster controversy - Ars Technica Skip to content Ars Technica home Sections Forum Subscribe Search AI Biz & IT Cars Culture Gaming Health Policy Science Security Space Tech Feature Reviews AI Biz & IT Cars Culture Gaming Health Policy Science Security Space Tech Forum Subscribe Story text Size Small Standard Large Width * Standard Wide Links Standard Orange * Subscribers only Β Β  Learn more Pin to story Theme HyperLight Day & Night Dark System Search Sign In Sign in dialog... Sign in the controversy continues Troubling new details emerge on diabetes ouster controversy American Diabetes Association blocked publication of op-ed articles so the authors posted them as a preprint. Jennifer Ouellette – Jul 17, 2026 1:08 pm | 20 Police escort Dr. Steven Kahn out of a medical conference in New Orleans for handing out copies of an editorial critical of the Trump administration. Credit: Screenshot/MedPage Today Police escort Dr. Steven Kahn out of a medical conference in New Orleans for handing out copies of an editorial critical of the Trump administration.

Credit: Screenshot/MedPage Today Text settings Story text Size Small Standard Large Width * Standard Wide Links Standard Orange * Subscribers only Β Β  Learn more Minimize to nav Last month, we reported on a troubling incident at the annual meeting of the American Diabetes Association (ADA) in New Orleans. On June 5, five leading scientists were ousted for handing out copies of an editorial, published in the journal Diabetes Care (an ADA journal) in April, sharply criticizing the Trump administration’s ongoing attacks on scientific research. There was a public outcry and (eventually) a personal apology from the ADA’s CEO for the heavy-handed response, but it seems the organization has not yet learned its lesson. The deputy editors of Diabetes Care have posted an editorial and seven accompanying opinion articles to a preprint serverβ€”handily contained in a single PDF fileβ€”that they say the ADA has refused to publish.

Source: https://arstechnica.com/science/2026/07/troubling-new-details-emerge-on-diabetes-ouster-controversy/